Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent patents cover new treatments for metabolic disorders

May 4, 2005

Oral-lyn insulin spray approved in Ecuador

May 4, 2005

FDA approval for Byetta

May 3, 2005

Update on the efficacy of rosuvastatin in hypercholesterolemia

May 3, 2005

Triglyceride levels have no effect on the benefits of rimonabant in overweight/obese patients

May 3, 2005

Model proposed to explain the species-specific effects of SB-497115

May 3, 2005

Elixir licenses growth hormone secretagogue from BMS

May 3, 2005

Evidence suggests a link between sleep disorders and metabolic syndrome in mice

May 2, 2005

New antidiabetic agents from Ligand and Takeda

May 2, 2005

ZLB Behring to study C1-INH concentrate for hereditary angioedema

May 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...